Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its ...

Former speed skater Sarah Lindsay, 44, believes injections like Ozempic and Mounjaro are causing users to be malnourished and ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

Talat Imran; Chief Executive Officer, Director; Rani Therapeutics Holdings Inc Svai Sanford; Chief Financial Officer; Rani Therapeutics Holdings Inc Welcome to the Rani fourth-quarter and full-year ...

Mounjaro — the diabetes medication that causes weight loss — can be purchased online, but it’s important to look for a reputable brand that ... like peptide (GLP-1) agonist and glucose ...

U.S. stock futures slipped on Monday night as the market awaited clarity from President Donald Trump regarding his tariff policy rollout. Futures tied to the Dow Jones Industrial Average fell by 86 ...

"With the surge in GLP-1 medication use for weight loss ... helps counteract muscle loss-a key concern for GLP-1 users. GLP-1 Support Fiber – With 15g of fiber per serving to support digestion ...

Ozempic (semaglutide) is a brand ... GLP-1 RAs also slow your digestion. This keeps you feeling fuller longer and reduces your appetite. These are the effects that cause weight loss.

Yet the weight-loss market, where Yu said 15% to 25% of people can't take GLP-1 drugs because they develop nausea, is big enough that "all parties can benefit." "We could do some real good in the ...